1st Edition

Biopharmaceuticals Challenges and Opportunities

By Basanta Behera Copyright 2021
294 Pages 91 B/W Illustrations
by CRC Press

294 Pages 91 B/W Illustrations
by CRC Press

Biopharmaceuticals: Challenges and Opportunities This book highlights how the traditional microbial process technology has been upgraded for the production of biologic drugs how manufacturing processes have evolved to meet the global market demand with quality products under the guidelines of internally recognized regulatory bodies. It also carries information on how, armed with a... Read more
Biopharmaceutical- A New Confront. Biopharmaceutical Production. Transitioning from Pharmaceutical to Biopharmaceutical. Biopharmaceutical from Animal cells. Plant Biomolecules and Therapeutic. Biosimilar. Biopharmaceutical Supply Chain Management.

Biography

Dr. Basanta Kumara Behera served as professor and director of biotechnology at three distinguished Indian universities, where he had been regularly associated with teaching and research at post graduate level courses on the topic related to Microbial processing technology, fermentation technology, biotechnology, genetic engineering, protein engineering, and therapeutic proteins. In 2009 he joined a MNS company as adviser for speciality chemicals production and drug design through microbial process technology. Prof. Behera is associated with national and international repute companies as technical adviser for the production of biopharmaceuticals under cGMP norms. Dr Behera has credit of being authored books published/in Springer Verlag, Germany; Elsevier USA; CABI, UK.

"This is an overview of the history and development of biologicals used in therapeutics, with a strong focus on the developmental process. Chapters cover regulation of these drugs, biosimilars, costs, and the future of personalized medicine with these products. The book starts with a history and overview of the development and use of biopharmaceutics. It then discusses current trends and future markets, including the personalized medicine implications. It is user friendly enough for readers to understand the science and robust enough for use in postgraduate studies and programs."

- Patrick J. McDonnell, Temple University School of Pharmacy